Adult Vaccine Market Global Forecast Report by Disease wise (Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, Tdap, Travel and Miscellaneous, Varicella) Countries and C

Adult Vaccine Market Global Forecast Report by Disease wise (Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, Tdap, Travel and Miscellaneous, Varicella) Countries and Company Analysis, 2024-2032


Adult Vaccine Market Analysis

The global adult vaccine market was valued at US$ 20. 59 billion in 2023 and is projected to reach US$ 35.87 billion by 2032 with the compound annual growth rate of 6.36% from 2024 to 2032. The human life span is stretching now than ever before, therefore making adult vaccination a critical measure in controlling spread of infectious diseases. A shift in the demography of a population and awareness to preventive measures of health have raised the frequency of adult immunization.

What is an Adult Vaccine?

Adult vaccines are vaccines which are specifically developed for those above the age of 18 years for the purpose of preventing invasive infections. While some of the vaccines are administered during childhood ones are administered to adults depending on their age, life style, health status, travel, and occupation. Such vaccines are used in the prevention of Influenza, pneumonia, hepatitis, shingles, and soon. The first vaccines are those which every individual need for one or another reason, for keeping the immunity raised, such as the tetanus booster, meanwhile there are vaccines which protect the population against new kinds of threats. Because immunity may decline after some time, adult immunization is important in establishing long steady and strong health, especially in the elderly or persons with underlying chronic diseases that give a severe disease. Annual, vaccines could have prevented the deaths of many adults in different parts of the world and greatly affected the world’s healthcare systems financially. Vaccine-preventable respiratory diseases like influenza and pneumococcal disease cost the global community more that 23 million years of life due to premature mortality.

Global Use and Significance

Adult vaccines have been widely utilized in the global community owing to increased consciousness of vaccine preventable diseases, increasing population of the aging persons and improvement on public health measures. High levels of vaccination are witnessed among developed nations in North America and Europe; healthcare is well developed and immunizations supported by government. But there is a shift towards advocate for improved uptake of adult vaccines in the emerging markets where knowledge and availability of vaccines are relatively low. Adult immunizations’ goal is to improve the health outcomes of people around the world through vaccine-preventable diseases among adults Ergo they are part of herd immunity, hence curtailing diseases transmission among people curtailing the burden on the health systems.

Growth Factors in the Adult Vaccine Industry

Increasing Awareness of Preventive Healthcare

Increased population of the seniors across the globe is a key driver to the growth of the adult vaccine market. People in their old age become more vulnerable to infections and several other complications due to the deterioration of the immune system. Use of specific vaccines such as the ‘adult’ vaccines including those meant for respiratory conditions for instance, flu as well as pneumonia has been on the rise among geriatric patients. The global increase of chronic diseases like, heart disease diabetes, respiratory diseases make it desirable for the vulnerable groups to be vaccinated. One of the main market drivers is the continually increasing number of people of aging population worldwide and the need for comprehensive programs of adult immunization and special vaccines.

Aging Population and Chronic Disease Prevalence

The rising global population of older adults is a significant growth factor for the adult vaccine market. As people age, their immune systems weaken, making them more susceptible to infectious diseases and complications. Vaccines tailored to adults, especially those targeting respiratory illnesses like flu and pneumonia, are increasingly in demand among the elderly. The prevalence of global chronic conditions such as heart disease, diabetes, and respiratory disorders heightens the need for vaccination in these vulnerable groups. As the aging population expands worldwide, the demand for effective adult immunization programs and tailored vaccines is expected to fuel industry growth.

Government Support: A Pillar of the Adult Vaccine Market

The most important factors affecting the adult vaccines market include government policies /immunization programs. Most of the countries are either administrating or planning to continue a national immunization program that incorporates adult vaccines, especially in the developing countries where the population aging rate is rapidly rising. Ones the vaccines are available in the market there are some incentives provided by public health organizations and government in way of subsidies and awareness and also through free or low-cost vaccination to increase coverage rates. Other organizations such as the WHO and the CDC also help in recommending and encouraging adult vaccines. They collectively provide a substantial boost to the market growth by making it easier and inviting more and more people to take adult vaccinations.

Asia Pacific: A Key Player in the Adult Vaccine Market

They are demonstrated to be part of the Asia Pacific region that has solidified as a promising market for the adult vaccines, with several countries intensifying their efforts towards healthcare security, and diversification of industry. It has been characterized by an explosive growth of the market. The country called the ‘pharmacy of the world’ was sending out COVID-19 vaccines to other countries up to May 2022 distributing more than the 60 percent of the global demand for vaccines. They have, both domestic and foreign, triggered a production increase. South Korea and Singapore alone have secured more than $3 billion in the past two years explicitly for vaccines, their research and manufacturing plants.

Global COVID-19 vaccine availability and distribution in 2022 showed that nations are significant to one another in terms of vaccine availability. Australia that has been striving to enhance domestic capacities for production imported over 70 million doses. On the other hand, capitalizing on their manufacturing prowess, India and China supplied 900 million and 750 million doses mainly to Africans and Latin Americas. For example, in the case of the China-ASEAN Free Trade Agreement, the dynamism in trade in biotech products including vaccines has also been realized. Given that the governments in Asia Pacific countries and the private players have made such investment in the preventive vaccines, the trends show a rosy picture for the preventive vaccines market in the near future.

Adult Vaccine Market Company Overview

The global adult vaccine market features prominent players such as GlaxoSmithKline, plc., AstraZeneca plc, Sanofi Pasteur, Pfizer, Inc., and CSL Limited. These industry leaders actively develop and distribute vaccines for the adult population globally.

Adult Vaccine Market News

In April 2024, Merck's Phase 3 trial STRIDE-10 results were released at the 34th ESCMID Global in Barcelona, Spain. The trial evaluated Merck's adult-specific 21-valent pneumococcal conjugate vaccination, V116, compared to PPSV23 in people 50 and older who had not received a pneumococcal vaccination before.
In August 2022, Pfizer-BioNTech COVID-19 mRNA vaccine is safe and effective, according to the WHO Strategic Advisory Group of Experts on Immunization (SAGE).

Disease Wise – Market breakup in 10 viewpoints:

1. Influenza
2. Cervical Cancer (HPV)
3. Zoster (Shingles)
4. MMR (Measles, Mumps, and Rubella Vaccine)
5. Pneumococcal
6. Meningococcal
7. Hepatitis
8. TdaP
9. Travel and Miscellaneous
10. Varicella

Country – Market breakup in 21 viewpoints:

North America

United States
Canada

Europe

United Kingdom
Germany
France
Russia
Italy
Spain
Switzerland

Asia Pacific

India
China
Japan
Australia
South Korea

Latin America

Brazil
Mexico
Argentina

Middle East & Africa

Saudi Arabia
United Arab Emirates
South Africa

Rest of the World

All the Key players have been covered from 5 Viewpoints:

• Overviews
• Key Person
• Recent Developments & Strategies
• Product Portfolio & Product Launch in Last 1 Year
• Revenue

Company Analysis:

1. GlaxoSmithKline, plc.
2. AstraZeneca plc
3. Sanofi Pasteur
4. Pfizer, Inc.
5. CSL Limited Dishwasher Market Analysis

The global dishwasher market has been estimated to be US$ 34.70 billion in 2023 and is expected to reach US$ 43.33 billion by 2032, with the Compound Annual Growth Rate of 2.50% during the forecast period of 2024 to 2032. The market growth is attributed to the rise in a disposable income, changes in consumer preferences, and advancement in dishwasher products.

Dishwasher Market Overview

A dishwasher is an electric machine to wash dishes, cutlery, cookers, pans, vessels and many other utensils. It employs hot water, detergent and physical scrubbing to wash of food particles, grease and other stains. Today’s models contain different wash options, folding metal arms and energy star models. These units clean through washing the dishes with water and detergent, use the rotating spray arms and heat wash to eliminate bacteria and other microorganisms from the objects. Also, it has soiling control to records the dirtiness of the dishes and adapts the wash cycle respectively and has the option of saving energy and water.

Dishwashers are also used differently across the globe with North America and western Europe being the biggest markets mainly because of convenience and time factors. In some parts of Asia, however, adoption has not been as swift because of cultural and space constraints along with small living areas, although use is steadily on the rise because of changing urban living situations and, of course, water scarcity. In the developing countries they are not very popular in homes but are widely used in the hotels and restaurants. There are various factors that have boosted the dishwasher market globally, the advancement in technology, changes in customers’ lifestyle and awareness on water and energy efficiency.

Growth Factors in the Dishwasher Industry

Technological advancements

Continual advances in technology have led to steady development in the dishwasher manufacturing business. Some of these include connecting the dishwasher to a Wi-Fi, voice control and the control of the dishwasher using the mobile application to monitor the progress of the dishwasher. It uses high technology sensors and artificial intelligence algorithms in management of water and energy to make certain that it is both effective and environmentally friendly. Novel washing features such as focused water spray and dedicated wash areas improve cleaning for complex foods and stains on dishes. Newer dishwaters have also come with even quieter motors and better insulation, meaning they can be installed in areas where people want to hear what is going on around them, such as in houses with an open plan. In addition, new technologies enhance user satisfaction, draw attention to tech-savvy consumers, contribute to the development of new markets and make existing users replace their appliances. Nov 2023, Hisense unveils the Smart Built-In Dishwasher with Autodose & Autodry, a smart dishwasher that features, data line liquid detergent auto-dousing and auto-dry door pop-out integrated in the U. S market.

Changing lifestyles and urbanization:

The main drivers which can be seen are changing life styles and increase rate in urbanization that is driving the dishwasher market. Because the awareness of urbanization is rising and consumers have many demands on the time that they cannot spend on washing dishes manually, the probability of using dishwashers also rises. The modern families are concentrating at two working persons per family reducing the time to manually wash the dishes hence dishwashers are deemed to fit the market well. Moreover, the small floor area in urban markets has promoted innovation in dishwasher designs in that white, space-saving designs are common in apartments. Another factor is the greater reliance and consumption of eating out and takeaway services which in turn enhances the application of dishwashers in canteens and eating places. Besides, as the level of Awareness of hygiene rises especially as a result of world health issues, dishwashers are considered more hygiene than hand washing hence the increased use of dishwashers at home and in business establishments.

Environmental consciousness and regulations:

The growth of the dishwasher business is a result of growing concerns of the environment and the enactment of strict energy standards. Due to demand from the consumers for the protection of environment, dish washers have evolved to be very efficient in its consumption of water and energy. Rules of displaying energy efficiency at home and eco-labeling programs have been established in many countries of the world for using more energy-efficient appliances. Such requirements are forcing governments to enactment policies that seek to eliminate older models from circulation; thus, ensuring that new and efficient, environmentally friendly models are on the market. It also concerns such aspects as environmentally friendly manufacturing and parts, for example, using recycled plastic in dishwashers’ parts, since buyer-conscious and legislative trends require it.

Europe Dishwasher Market Overview:

Europeans are now inexorably more occupied than before, have admitted that they no longer have time for manual washing of dishes hence require dishwasher. Improved and water-efficient European dishwashers with efficiency standards of Energy Star are on the rise in the European market. Again, Europeans have higher disposable income and therefore the consumer will be more willing to purchase anything that will ease their lives, including appliances. Also, the segment of reliance on an online store should increase at a higher rate due to specified promotions and convenient shopping. In September 2023, Electrolux AB launched a new product in the compact dishwasher range that it called the 55cm UltimateCare 300 with eight place settings. This is free for basic installation in Western European countries and is accompanied by additional extras like the ‘Eco program mode’ and child lock system.

Dishwasher Market Company Overview

Industry leaders seen in the Global Dishwasher Market Include Electrolux AB, Panasonic, Whirlpool, Robert Bosch Gmbh, Samsung, Siemens, LG Electronics, and Haiers.

Dishwasher Market News

April 2023: Haier aimed for a 33% turnover growth in 2023 and planned to invest USD 183 million for expansion by 2025.
Haier introduced the Jingcai Dishwasher in August 2023. It features an Auto Dry intelligent door opening, quick drying and washing, sections, and space for up to 109 dish pieces at once. It uses less water and energy and protects the environment by securely cleaning and sterilizing dishes and removing germs and food residues.
In November 2022, with the opening of a new dishwashing factory in Turkey, Haier Europe increased its production capacity. By making this step, Haier solidified its position as the leading appliance manufacturer in Europe and took the lead in a number of product categories.
In November 2022, Whirlpool Corporation acquired InSinkErator, the largest producer of food waste disposers and instant hot water dispensers for residential and commercial use worldwide, from Emerson. Emerson now completely owns InSinkErator.

Product – Market breakup in 2 viewpoints:

1. Freestanding
2. Built-in

Application – Market breakup in 2 viewpoints:

1. Commercial
2. Residential

Distribution Channel – Market breakup in 2 viewpoints:

1. Offline
2. Online

Country – Market breakup in 25 viewpoints:

• North America

United States
Canada

• Europe

France
Germany
Italy
Spain
United Kingdom
Belgium
Netherlands
Turkey

• Asia Pacific

China
Japan
India
Australia
South Korea
Thailand
Malaysia
Indonesia
New Zealand

• Latin America

Brazil
Mexico
Argentina

• Middle East & Africa

South Africa
Saudi Arabia
United Arab Emirates

All the Key players have been covered from 5 Viewpoints:

1. Overviews
2. Key Person
3. Recent Developments & Strategies
4. Product Portfolio & Product Launch in Last 1 Year
5. Revenue

Company Analysis:

1. Electrolux AB
2. Panasonic
3. Whirlpool
4. Robert Bosch Gmbh
5. Samsung
6. Siemens
7. LG Electronics
8. Haiers Wound Care Market Analysis

The global wound care market has been valued at US$ 20. 36 billion in 2023 and it is expected to rise to US$ 33.63 billion by 2032, with a consequently establishing a compound annual growth rate of 5.73% from 2024 to 2032. The major growth forces that put on the market are demographic tendencies, which include the rising proportion of elderly consumers and increasing rates of chronic diseases including diabetic issues and obesity.

Wound Care Market Overview

A wound is any infringement that happens to skin or any other tissue, it can be a cut, a tear, a puncture, etc. They are classified in to open and closed and range from simple injuries such as incisions, laceration, burns to complex one resulting from accidents, operations or underlying illnesses. The normal healing starts as soon as the tissues are injured and include clotting of the blood, inflammation, tissue repair, and formation of a scar. Nevertheless, proper management of wound is essential for such healing process, infection control and to enhance the gain.

Wound care products are on the rise due to the increase in surgical procedures that take place as well as the increase in the incidences of chronic diseases across the globe. The rising prevalence of diabetes, brought by a sedentary lifestyle is one of the major drivers of this market.

Growth Factors in the Wound Care Industry

Aging Population and Chronic Diseases

One of the most important forces impacting the global wound care market is the increasing incidence of ageing populace. These include pressure ulcers, diabetic foot ulcers and post-surgical wound injuries which are more prevalent among the elderly owing to the fact that they have lean skin and slow healing ability. Also, life expectancy and the common incidence of chronic diseases such as diabetes and obesity raise the chances of encountering complicated wounds. For instance, diabetes causes foot ulcers which if not well taken care off may become very complicated. Thus, the increased demand for more superior quality wound care products comprising of dressings, wound healing agents, and devices is proving to be on the raise as healthcare organizations seek to enhance their care delivery and patient outcomes especially for patients requiring long-term care. For instance, CDC reported that by April 2023, the total population of the United States, 3 million people have been diagnosed with diabetes and 96 million American adults are living with prediabetes.

Technological Advancements and Innovative Products

The wound care industry is on the rise due to the increase in technology and development of new products in the market. There are new materials, hydrocolloids and alginates that provide better healing networks and quick recovery, bioactive dressings. Other aspects that can be tailored are smart technologies like moisture control sensors as well as the wound monitoring systems. These innovations have extended the market for next generation of wound care dressings beyond the basic range. Besides, medical devices such as NPWT devices, antimicrobial dressings and bioengineered skin substitutes have evolved and have become quite affordable, thus enhancing the treatment processes. Ongoing research in the injured tissue care products are expected to improve further the efficiency of wound care solutions and therefore fueling the market growth. For example, in early January 2023, scientists of the University of Arizona College of Medicine have designed a smart bandage with enhanced electronics for the stimulation of the tissue regeneration process. It uses electricity, biosensors displaying different signals, for the purpose of increasing blood circulation to damaged tissues to increase the rate of wound healing and reduce scar tissue.

Growing Awareness and Healthcare Infrastructure Development

The market is growing due to the rising knowledge of wound care management amongst various healthcare assuring practitioners and patients. Campaigns and organizational crusades to promote early wound care and the risks associated with infections have put pressure and created awareness on consumers to seek enhanced forms of wound management. At the same time, the development of the healthcare system, particularly in the developing countries, has led to the availability of the required products and services related to wound care. Authorities and private sector are putting their money in enhancement of hospitals and clinics as well as wounds care centers. Furthermore, ageing population is imposing greater demands on healthcare and, consequently, on wound care costs and technologies; the healthcare insurance policies also provide patients with an ability to pay for more expensive products contributing to the industry growth. The markets which include the rural and urban markets are thus experiencing enhanced adoption of wound care.

China Wound Care Market Overview

China’s wound care market is expanding steadily because of growing aging populations, rising incidence of chronic diseases, and enhancing healthcare systems. The market includes many types of products, and domestic and import wound care firms consider the market appealing. Thus, government driven demands towards a quantitative enhancement of the quality of healthcare have fueled market growth. Programs aiming at improving the control of diabetes, as well as the management of chronic wounds have also boosted consumption of the advanced wound care markets. The general trend that illustrates the development of new generation wound care products is still largely driven by basic products with rural markets still dominating the market share. So far in 2022, the NMPA has approved 210 medical devices, with only one wound care – an NPWT kit from Nantong Changyu Medical Technology Co., Ltd.

Wound Care Market Company Overview

Some of the prominent companies in the Global Wound Care Market are Mölnlycke Healthcare, Smith & Nephew, Ethicon Inc (a subsidiary of Johnson & Johnson), Coloplast Corp, ConvaTec Group PLC, and Derma Sciences Inc (now part of Integra LifeSciences). These companies are known for their significant contributions to the field of wound care and have established themselves as industry leaders with innovative products and solutions.

Wound Care Market News

In September 2023, MiMedx Group, Inc. introduced EPIEFFECT, an enhanced wound care solution, to expand its product offering.
In June 2023, JeNaCell introduced the wound dressing elicit balance on the German market. Pressure ulcers, diabetic foot ulcers, venous leg ulcers, arterial leg ulcers, and soft tissue lesions—chronic wounds with low to medium exudation are the best candidates for this treatment. This calculated launch aimed to increase sales and broaden the company's product line.
In May 2023, Vizient, Inc. awarded Smith & Nephew a cutting-edge technology contract for its PICO Single Use Negative Pressure Wound Therapy Systems.
In March 2023, Bactiguard AB introduced its range of wound care products in Ireland and the United Kingdom in partnership with Quintess Medical. The corporation wanted to improve its standing in the nation through this partnership.

Wound Type – Market breakup in 5 viewpoints:

1. Advanced wound Dressings
2. Traditional Wound Care Products
3. Negative Pressure Wound Therapy
4. Bioactive
5. Others

Products – Market breakup in 11 viewpoints:

1. Growth Factors
2. Foam
3. Antimicrobial
4. Alginate
5. Traditional Adhesive
6. Hydrocolloid
7. Hydrogel
8. Traditional Gauze
9. Film
10. Traditional non-adherent
11. Others

Application – Market breakup in 2 viewpoints:

1. Chronic Wounds
2. Acute Wounds

End User – Market breakup in 3 viewpoints:

1. Home Care Settings
2. Long-term care Facilities
3. Hospital & Clinics

Country – Market breakup in 25 viewpoints:

North America

United States
Canada

Europe

France
Germany
Italy
Spain
United Kingdom
Belgium
the Netherlands
Turkey

Asia Pacific

China
Japan
India
Australia
South Korea
Thailand
Malaysia
Indonesia
New Zealand

Latin America

Brazil
Mexico
Argentina

Middle East & Africa

South Africa
Saudi Arabia
United Arab Emirates

All the Key players have been covered from 5 Viewpoints:

• Overviews
• Key Person
• Recent Developments & Strategies
• Product Portfolio & Product Launch in Last 1 Year
• Revenue

Company Analysis:

1. Mölnlycke Healthcare
2. Smith & Nephew
3. Ethicon Inc (Johnson & Johnson)
4. Coloplast Corp
5. ConvaTec Group PLC
6. Derma Sciences Inc. (Integra LifeSciences) Global Vitiligo Market Size

Global vitiligo market is worth around US$ 641 billion in 2023 and it is expected to reach approximately US$ 1,041 billion by 2032, with a CAGR of about 5.55% from 2024-2032. The measures that are benefiting this market include enhanced knowledge of people about vitiligo, as well as the innovations that are availed for treatment.

Vitiligo Industry Outlooks

Vitiligo is a chronic ailment that is classified under the autoimmune disorders which results to depigmentation and manifest in white colors parts of the body. This condition results from either the death of melanocytes, or stop work, and therefore no skin color is produced. The cause of vitiligo though not well defined, the fatty diet is believed to be inherited though some factors from the environment.

Vitiligo management strategies encompass measures that seek to reform the depigmented skin and strop further progression. These are Topical corticosteroids and immunomodulators, Phototherapy (UVB light or PUVA), Oral medications for corticosteroids or JAK inhibitors, depigmentation in severe cases and Skin grafting or cellular grafting in certain conditions.

Furthermore, camouflage makeup and self-tanning products are effective ways of covering areas with certain skin conditions. Counseling could also help for, as vitiligo is becoming a source of stress or depression among affected people. Currently, there is no known cure for vitiligo, though the above treatments are effective in managing patients’ condition and enhancing their appearance. The need for further research means that new therapeutic interventions’ possibilities are still pursued today.

Growth Drivers of the Global Vitiligo Market

Increasing prevalence and awareness:

Currently, vitiligo is becoming more widespread and is primarily diagnosed in between 1 and 2 percent of the total global population. This rise is attributed to enhanced detecting methods and specially increased patient awareness and that of healthcare practitioners. When more people identify the signs and symptoms of the diseases, and visit the doctors, there is increase in the market for the medication. Having personalities such as musician Beyoncé or footballer Marc Batchelor come out in the open to publicly share their experiences with vitiligo have gone a long way in eradicating or at least reducing the stigmatization of the persons afflicted with vitiligo. It also increases an awareness of the conditions among people, thereby motivating them to come for treatment and the progression of the market. On the same note, the roles of patients’ organizations and informative campaigns play a vital role in informing the community, and the general public more often on vitiligo and its effects on the life of an affected patient together with the existing treatment modalities. These increasing awareness levels are expected to drive the market in the future years.

Advancements in treatment options:

The present activity of increasing research in the pharmacological sector to develop new products in the management of vitiligo is extending the market widely. Some recent advancements are Janus kinase inhibitors which have emerged to be effective in the clinical trials. These new drugs hold the potential for more effective and indeed, targeted thanks to this new generation, therapy of this and other diseases. Moreover, advancement in the source of light and technology as well as advancement in treating techniques including the technique of giving narrowband UVB and the application of excimer laser therapy in treatment have been enhancing. Combination treatments in which two or more techniques are used are becoming more popular as they provide better results. Other areas of growth involve the usage of genetic and environmental factors in developing targeted medical solutions for the individual patient including personalized medicine approaches. These new generation treatments are projected to fuel the growth and get more acceptance from approval bodies hence propelling the growth of vitiligo treatment market and attract investors.

Growing aesthetic concerns and quality of life considerations:

In today’s world where people are sensitive about esteeming concerns, looks appear to take on a social and or professional value. Vitiligo, an easily noticeable skin disorder, plays a large role in the patient’s low self-esteem and a diminished quality of life. This coupled with the increasing concern from people, treatment therapies that are non-surgical are in high demand as people seek ear treatments not only for health issues but also for cosmetic and morale boosting purposes. This aspect of the treatment with vitiligo is also beginning to shape the market significantly with patients demanding solutions to regain the lost skin color. This trend is particularly strong across the generations with increased influence among the young and in areas where the culture placed significant emphasis on the appearance of an individual. The market is using every possible product, ranging from medical, to make-up creams and dyes that address these issues. Hence the focus on quality of life and appearance will contribute to the continuous growth of vitiligo treatment market.

United States Vitiligo Market

The United States vitiligo market is today deemed as one of the most significant and promising submarkets in the global dermatology industry. Currently, it is predicted that between 2 to 5 million Americans suffer from vitiligo hence the market is ripe for expansion and development. The U. S. market enjoys a strong health care infrastructure, high health care awareness, and research and development financial outlay. Some of the leading market players are currently working on creating new drugs, moreover, most of the initiatives are aimed at the creation of biologics and targeted therapies. For instance, the latest approval of ruxolitinib cream for vitiligo therapy has given a boost into the market and thus opening up new innovations. Besides, there has been growth in the use of ‘dual-hit therapies’ as well as ‘treat the patient’ regimen.

The U. S. vitiligo market therefore has also strong patient associations that are very useful in raising public awareness and campaigning for improved therapy. These factors entailing favou


1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.2 Challenges
5. Global Adult Vaccines Market
5.1 Market
5.2 Volume (people)
6. Market & Numbers Share Analysis
6.1 Adult Vaccine Market Share
6.2 By Country Adult Vaccine Market Share
6.3 Adult Vaccinated Population Share
7. Disease wise – Adult Vaccines Market
7.1 Influenza
7.2 Cervical Cancer (HPV)
7.3 Zoster (Shingles)
7.4 MMR (Measles, Mumps, and Rubella Vaccine)
7.5 Pneumococcal
7.6 Meningococcal
7.7 Hepatitis
7.8 TdaP
7.9 Travel and Miscellaneous
7.10 Varicella
8. Disease wise – Numbers of Vaccinated Adults
8.1 Influenza
8.2 Cervical Cancer (HPV)
8.3 Zoster (Shingles)
8.4 MMR
8.5 Pneumococcal
8.6 Meningococcal
8.7 Hepatitis
8.8 TdaP
8.9 Varicella
9. By Country
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Russia
9.2.5 Italy
9.2.6 Spain
9.2.7 Switzerland
9.3 Asia-Pacific
9.3.1 India
9.3.2 China
9.3.3 Japan
9.3.4 Australia
9.3.5 South Korea
9.4 Latin Africa
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
9.5 Middle East and Africa
9.5.1 Saudi Arabia
9.5.2 UAE
9.5.3 South Africa
9.6 Rest of the World
10. Porter’s Five Forces
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1 Strengths
11.2 Weaknesses
11.3 Opportunities
11.4 Threats
12. Mergers and Acquisitions in the Vaccine Industry
13. Vaccines and Regulator’s Interventions
13.1 Making and Meeting Standards of Quality and Safety
13.2 Vaccine Funding
14. Vaccines – Products and Pipeline
14.1 GSK Vaccine Product Pipeline
14.2 AstraZeneca plc Vaccine Product Pipeline
14.3 Sanofi Vaccine Product Pipeline
14.4 Pfizer Vaccine Product Pipeline
15. Vaccines Key Players Analysis
15.1 GlaxoSmithKline, plc.’s Vaccines Sales
15.1.1 Overviews
15.1.2 Key Person
15.1.3 Recent Developments & Strategies
15.1.4 Product Portfolio & Product Launch in Last 1 Year
15.1.5 Revenue
15.2 AstraZeneca plc Vaccines Sales
15.2.1 Overviews
15.2.2 Key Person
15.2.3 Recent Developments & Strategies
15.2.4 Product Portfolio & Product Launch in Last 1 Year
15.2.5 Revenue
15.3 Sanofi Pasteur’s Vaccines Sales
15.3.1 Overviews
15.3.2 Key Person
15.3.3 Recent Developments & Strategies
15.3.4 Product Portfolio & Product Launch in Last 1 Year
15.3.5 Revenue
15.4 Pfizer, Inc.’s Vaccines Sales
15.4.1 Overviews
15.4.2 Key Person
15.4.3 Recent Developments & Strategies
15.4.4 Product Portfolio & Product Launch in Last 1 Year
15.4.5 Revenue
15.5 CSL Limited sales
15.5.1 Overviews
15.5.2 Key Person
15.5.3 Recent Developments & Strategies
15.5.4 Product Portfolio & Product Launch in Last 1 Year
15.5.5 Revenue

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings